Presbia to Participate in Jefferies 2017 Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)--Presbia PLC (NASDAQ:LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6th, at 11:30 a.m. ET. The Conference will take place in New York at the Grand Hyatt from June 6